NEXT Biometrics Group ASA (OSL:NEXT)
Norway · Delayed Price · Currency is NOK 0.2450
-0.0210 (-7.89%)
Sep 14, 2026, 4:25 PM CET
NEXT Biometrics Group ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 10.07 | 13.36 | 19.68 | 34.38 | 46.51 | 49.79 |
Other Revenue | - | - | - | - | 1.78 | 0.97 |
| 10.07 | 13.36 | 19.68 | 34.38 | 48.29 | 50.76 | |
Revenue Growth | -26.51% | -32.10% | -42.76% | -28.80% | -4.85% | -12.17% |
Cost of Revenue | 24.98 | 13.55 | 16.78 | 27 | 33.54 | 40.68 |
Gross Profit | -14.91 | -0.19 | 2.9 | 7.38 | 14.75 | 10.07 |
Selling, General & Admin | 33.9 | 34.3 | 30.83 | 34.24 | 33.45 | 38.49 |
Research & Development | - | - | - | - | 5.52 | - |
Other Operating Expenses | 48.19 | 40.85 | 42.16 | 31.18 | 16.62 | 22.81 |
Operating Expenses | 86.77 | 80.4 | 78.83 | 72.66 | 62.82 | 68.32 |
Operating Income | -101.68 | -80.59 | -75.93 | -65.28 | -48.07 | -58.25 |
Interest Expense | -0.96 | -0.26 | -0.14 | -0.3 | -0.13 | -0.35 |
Interest & Investment Income | 0.56 | 0.56 | 1.48 | 1.05 | 0.71 | 0.71 |
Currency Exchange Gain (Loss) | -0.1 | -0.1 | -0.33 | -0.07 | 1.08 | 0.11 |
Other Non Operating Income (Expenses) | -0.03 | -0.02 | 0.02 | 0.24 | 0.01 | -0.61 |
EBT Excluding Unusual Items | -102.21 | -80.41 | -74.9 | -64.36 | -46.39 | -58.39 |
Asset Writedown | -2.13 | - | - | -1.14 | - | - |
Pretax Income | -104.33 | -80.41 | -74.9 | -65.5 | -46.39 | -58.39 |
Income Tax Expense | 0.11 | 0.13 | 0.2 | 0.23 | -0.06 | 1.62 |
Net Income | -104.45 | -80.54 | -75.1 | -65.73 | -46.33 | -60.01 |
Net Income to Common | -104.45 | -80.54 | -75.1 | -65.73 | -46.33 | -60.01 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 23 | 12 | 11 | 10 | 9 | 9 |
Shares Outstanding (Diluted) | 23 | 12 | 11 | 10 | 9 | 9 |
Shares Change | 109.98% | 8.33% | 12.68% | 3.66% | 2.85% | - |
EPS (Basic) | -4.56 | -6.93 | -7.00 | -6.91 | -5.05 | -6.72 |
EPS (Diluted) | -4.56 | -6.93 | -7.00 | -6.91 | -5.05 | -6.72 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -66.24 | -71.76 | -62.28 | -56.64 | -33.19 | -47.89 |
Free Cash Flow Per Share | -2.89 | -6.18 | -5.81 | -5.95 | -3.62 | -5.37 |
Gross Margin | -148.06% | -1.40% | 14.74% | 21.46% | 30.55% | 19.85% |
Operating Margin | -1009.62% | -603.04% | -385.81% | -189.85% | -99.54% | -114.77% |
Profit Margin | -1037.11% | -602.69% | -381.58% | -191.18% | -95.94% | -118.24% |
Free Cash Flow Margin | -657.71% | -536.97% | -316.45% | -164.74% | -68.73% | -94.34% |
EBITDA | -99.73 | -78.04 | -72.65 | -60.29 | -42.73 | -52.91 |
EBITDA Margin | - | - | - | -175.33% | -88.48% | -104.25% |
D&A For EBITDA | 1.95 | 2.56 | 3.29 | 4.99 | 5.34 | 5.34 |
EBIT | -101.68 | -80.59 | -75.93 | -65.28 | -48.07 | -58.25 |
EBIT Margin | - | - | - | -189.85% | -99.54% | -114.77% |